David Lennon
Chief Executive Officer chez AADI BIOSCIENCE, INC.
Fortune : - $ au 31/03/2024
Profil
David Lennon is currently the Chief Executive Officer & Director at Satellite Biosciences, Inc., the President, Chief Executive Officer & Director at Aadi Bioscience, Inc., the Vice Chairman at Alliance for Regenerative Medicine, and the Managing Director & GM-Oncology Business at Novartis Pharma KK.
He previously worked as the President at Novartis AG and the President at Novartis Gene Therapies, Inc. Dr. Lennon holds a doctorate degree from Weill Cornell Medical College and an undergraduate degree from Columbia College (New York).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AADI BIOSCIENCES, INC.
-.--% | 01/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de David Lennon
| Sociétés | Poste | Début |
|---|---|---|
| AADI BIOSCIENCE, INC. | Chief Executive Officer | 02/10/2023 |
Novartis Pharma KK
 Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | Director/Board Member | 01/06/2017 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | 21/10/2021 |
Satellite Biosciences, Inc.
 Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Chief Executive Officer | 01/06/2021 |
Anciens postes connus de David Lennon
| Sociétés | Poste | Fin |
|---|---|---|
| AVEXIS INC | President | 01/07/2021 |
| NOVARTIS AG | President | - |
Formation de David Lennon
| Weill Cornell Medical College | Doctorate Degree |
| Columbia College (New York) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVARTIS AG | Health Technology |
| AADI BIOSCIENCE, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Novartis Pharma KK
Novartis Pharma KK Pharmaceuticals: MajorHealth Technology Novartis Pharma KK develops, imports, produces and sells pharmaceutical products. The company was founded on April 1, 1997 and is headquartered in Tokyo, Japan. | Health Technology |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
Satellite Biosciences, Inc.
Satellite Biosciences, Inc. BiotechnologyHealth Technology Satellite Biosciences, Inc. is a company based in Cambridge, MA that is focused on developing innovative regenerative medicine solutions to tackle some of the most challenging diseases. The company's mission is to create a new category of regenerative medicine called Tissue Therapeutics. The company was founded by Sangeeta N. Bhatia, Christopher S. Chen, and Arnav Chhabra. David Lennon has been the CEO of the company since 2021. | Health Technology |
